Operator
Good day, and welcome to the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2026. Our next presenting company is Daxor Corporation. [Operator Instructions] I’d now like to turn the floor over to today’s host, Michael Feldschuh, President and Chief Executive Officer at Daxor Corporation. Please go ahead.
Michael Feldschuh
Chairman, President & CEO
Thank you very much, and good afternoon to everybody. A pleasure to be speaking at this conference. I am Michael Feldschuh, Daxor’s CEO. So we will start with our usual disclosure slide about forward-looking statements. Okay. So who is Daxor and what is it that we are focused on? Daxor is a company that is a NASDAQ-listed company that is focused on advancing our mission of enabling optimal fluid management through blood volume analysis throughout the entire healthcare system.
Our vision is that all patients should have optimal blood volume management. Daxor is headquartered in Oak Ridge, Tennessee. We have a fully owned 20,000 square foot operating facility. It is a state-of-the-art center where we do both research and development and production. It is located in Oak Ridge, which is a center for nuclear medicine. We have a vertically integrated infrastructure there where we are able to produce both the companion analyzers that we use and capacity of up to 200,000 test kits per year for our diagnostic test.
So first of all, fundamentally, what is Daxor? Daxor is a diagnostic company, specifically a pharmaceutical diagnostic company and even more specifically, a radiopharmaceutical diagnostic company. We produce a diagnostic drug called Volumex. Volumex is a diagnostic drug, which is injected into a patient. It is allowed to circulate and then the blood from that patient
Read the full article here